Literature DB >> 6247738

Interaction of ambient temperature with the effects of delta 9-tetrahydrocannabinol on brain catecholamine synthesis and plasma corticosterone levels.

A S Bloom, C J Kiernan.   

Abstract

The effects of delta 9-tetrahydrocannabinol (THC) on body temperature, catecholamine synthesis and plasma corticosteroid levels were examined in the mouse at ambient temperatures of 31 degrees, 20 degrees and 10 degrees C in order to study the role of hypothermia in the THC's other actions. THC produced hypothermia at 10 degrees and 20 degrees C, but not at 31 degrees C. Dose related increases in dopamine and norepinephrine synthesis rates and plasma corticosterone levels were produced by THC at both 31 degrees and 20 degrees C. The effects of THC at 10 degrees C were biphasic. These data indicate that the effects of THC on brain catecholamines are not a result of drug induced hypothermia and may be a result of a direct action on neurons.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247738     DOI: 10.1007/bf00431259

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  A NEW CONCEPT OF TEMPERATURE REGULATION BY AMINES IN THE HYPOTHALAMUS.

Authors:  W FELDBERG; R D MYERS
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

2.  CHANGES IN TEMPERATURE PRODUCED BY MICRO-INJECTIONS OF AMINES INTO THE ANTERIOR HYPOTHALAMUS OF CATS.

Authors:  W FELDBERG; R D MYERS
Journal:  J Physiol       Date:  1965-03       Impact factor: 5.182

3.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

4.  Storage and synthesis of norepinephrine in the reserpine-treated rat brain.

Authors:  J Glowinski; L L Iversen; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-03       Impact factor: 4.030

5.  Daily rhythm in the accumulation of brain catechol-amines synthesized fom circulating H3-tyrosine.

Authors:  M J Zigmond; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

6.  Corticosterone elevation mediated centrally by delta 1-tetrahydrocannabinol in rats.

Authors:  R K Kubena; J L Perhach; H Barry
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

7.  An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant.

Authors:  J C Cradock; J P Davignon; C L Litterst; A M Guarino
Journal:  J Pharm Pharmacol       Date:  1973-04       Impact factor: 3.765

8.  A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.

Authors:  A S Bloom; W L Dewey
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

9.  Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol.

Authors:  K I MacLean; J M Littleton
Journal:  Eur J Pharmacol       Date:  1977-01-21       Impact factor: 4.432

10.  1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse.

Authors:  D Holtzman; R A Lovell; J H Jaffe; D X Freedman
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

View more
  9 in total

Review 1.  Endocannabinoid signalling: has it got rhythm?

Authors:  Linda K Vaughn; Gerene Denning; Kara L Stuhr; Harriet de Wit; Matthew N Hill; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Authors:  Erica Y Shen; Syed F Ali; Jerrold S Meyer
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

Review 3.  Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Cecilia J Hillard; Margaret Beatka; Jenna Sarvaideo
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

4.  Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.

Authors:  Christopher J Roberts; Kara L Stuhr; Michael J Hutz; Hershel Raff; Cecilia J Hillard
Journal:  Pharmacol Biochem Behav       Date:  2013-12-05       Impact factor: 3.533

5.  Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.

Authors:  Elisa Pabon; Frederica Rockwood; Greg J Norman; Harriet de Wit
Journal:  Psychophysiology       Date:  2021-10-19       Impact factor: 4.348

6.  Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.

Authors:  F Molina-Holgado; E Molina-Holgado; M L Leret; M I González; T A Reader
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

7.  Investigations on behavioral effects of an extract of Cannabis sativa L. in the rat.

Authors:  S Ferri; G Costa; G Murari; A M Panico; E Rapisarda; E Speroni; R Arrigo-Reina
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Delineation of domains within the cannabinoid CB1 and dopamine D2 receptors that mediate the formation of the heterodimer complex.

Authors:  Shazina S Khan; Frank J S Lee
Journal:  J Mol Neurosci       Date:  2013-11-22       Impact factor: 3.444

Review 9.  Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine.

Authors:  Paul J Fitzgerald
Journal:  Subst Abuse       Date:  2013-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.